BBM — Blueberries Medical Cashflow Statement
0.000.00%
- CA$4.95m
- CA$4.93m
- CA$0.31m
Annual cashflow statement for Blueberries Medical, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.15 | -1.47 | -1.64 | -1.15 | -1.67 |
| Depreciation | |||||
| Non-Cash Items | 3.01 | -0.214 | 0.502 | 0.248 | 0.416 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.371 | -0.083 | -0.348 | -0.002 | -0.091 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -1.68 | -1.47 | -1.33 | -0.797 | -1.24 |
| Capital Expenditures | -0.049 | 0 | -0.022 | 0 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0.102 | 0.405 | 0.009 | 0 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -0.049 | 0.102 | 0.383 | 0.009 | 0 |
| Financing Cash Flow Items | — | — | — | — | 0.131 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.77 | 1.35 | 0.539 | -0.002 | 1.18 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.04 | 0.07 | -0.595 | -0.752 | -0.04 |